Inovio Pharmaceuticals Inc (INO)
4.065
+0.10
(+2.39%)
USD |
NASDAQ |
Nov 21, 16:00
4.065
0.00 (0.00%)
After-Hours: 20:00
Inovio Pharmaceuticals Shareholders Equity (Quarterly): 73.54M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 73.54M |
June 30, 2024 | 96.74M |
March 31, 2024 | 94.44M |
December 31, 2023 | 117.35M |
September 30, 2023 | 138.16M |
June 30, 2023 | 169.37M |
March 31, 2023 | 199.21M |
December 31, 2022 | 222.36M |
September 30, 2022 | 266.70M |
June 30, 2022 | 297.67M |
March 31, 2022 | 355.08M |
December 31, 2021 | 399.67M |
September 30, 2021 | 453.57M |
June 30, 2021 | 508.55M |
March 31, 2021 | 581.61M |
December 31, 2020 | 461.14M |
September 30, 2020 | 323.90M |
June 30, 2020 | 186.26M |
March 31, 2020 | 184.32M |
December 31, 2019 | 3.435M |
September 30, 2019 | 33.69M |
June 30, 2019 | 53.62M |
March 31, 2019 | 77.91M |
December 31, 2018 | 86.94M |
September 30, 2018 | 103.61M |
Date | Value |
---|---|
June 30, 2018 | 111.40M |
March 31, 2018 | 113.00M |
December 31, 2017 | 142.39M |
September 30, 2017 | 162.02M |
June 30, 2017 | 123.43M |
March 31, 2017 | 105.85M |
December 31, 2016 | 123.28M |
September 30, 2016 | 146.88M |
June 30, 2016 | 161.99M |
March 31, 2016 | 170.97M |
December 31, 2015 | 175.69M |
September 30, 2015 | 193.14M |
June 30, 2015 | 180.56M |
March 31, 2015 | 103.12M |
December 31, 2014 | 111.23M |
September 30, 2014 | 116.73M |
June 30, 2014 | 121.84M |
March 31, 2014 | 128.74M |
December 31, 2013 | 52.46M |
September 30, 2013 | 61.76M |
June 30, 2013 | 29.20M |
March 31, 2013 | 39.93M |
December 31, 2012 | 34.35M |
September 30, 2012 | 30.76M |
June 30, 2012 | 35.83M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
3.435M
Minimum
Dec 2019
581.61M
Maximum
Mar 2021
256.66M
Average
210.79M
Median
Shareholders Equity (Quarterly) Benchmarks
Novavax Inc | -526.44M |
Baxter International Inc | 7.872B |
AIM ImmunoTech Inc | 2.912M |
Protalix BioTherapeutics Inc | 32.44M |
Armata Pharmaceuticals Inc | -50.97M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 107.06M |
Total Liabilities (Quarterly) | 33.52M |